Corvus Pharmaceuticals, Inc. Shares Issued
Corvus Pharmaceuticals, Inc. (CRVS) had Shares Issued of 84.12 million shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesIssued · last filed 2026-08-06
- 2026-06-30: Common Stock, Shares, Issued 84.12M shares.
- 2026-03-31: Common Stock, Shares, Issued 84.09M shares.
- 2025-12-31: Common Stock, Shares, Issued 74.70M shares.
- 2025-09-30: Common Stock, Shares, Issued 74.68M shares.
| Period end | Common Stock, Shares, Issued |
|---|---|
| 2026-06-30 | 84.12M shares 10-Q · filed 2026-08-06 |
| 2026-03-31 | 84.09M shares 10-Q · filed 2026-05-07 |
| 2025-12-31 | 74.70M shares 10-Q · filed 2026-08-06 |
| 2025-09-30 | 74.68M shares 10-Q · filed 2025-11-04 |
| 2025-06-30 | 74.51M shares 10-Q · filed 2025-08-07 |
| 2025-03-31 | 68.17M shares 10-Q · filed 2025-05-08 |
| 2024-12-31 | 67.90M shares 10-K · filed 2026-03-12 |
| 2024-09-30 | 62.58M shares 10-Q · filed 2024-11-12 |
| 2024-06-30 | 62.55M shares 10-Q · filed 2024-08-06 |
| 2024-03-31 | 49.04M shares 10-Q · filed 2024-05-07 |
| 2023-12-31 | 49.04M shares 10-K · filed 2025-03-25 |
| 2023-09-30 | 49.04M shares 10-Q · filed 2023-11-07 |
| 2023-06-30 | 48.90M shares 10-Q · filed 2023-08-08 |
| 2023-03-31 | 46.57M shares 10-Q · filed 2023-05-08 |
| 2022-12-31 | 46.55M shares 10-K · filed 2024-03-19 |
| 2022-09-30 | 46.55M shares 10-Q · filed 2022-11-03 |
| 2022-06-30 | 46.55M shares 10-Q · filed 2022-08-08 |
| 2022-03-31 | 46.55M shares 10-Q · filed 2022-05-05 |
| 2021-12-31 | 46.55M shares 10-Q · filed 2022-11-03 |
| 2021-09-30 | 46.55M shares 10-Q · filed 2021-11-01 |
| 2021-06-30 | 42.42M shares 10-Q · filed 2021-08-02 |
| 2021-03-31 | 38.31M shares 10-Q · filed 2021-04-29 |
| 2020-12-31 | 28.37M shares 10-K · filed 2022-03-10 |
| 2020-09-30 | 28.06M shares 10-Q · filed 2020-10-29 |
| 2020-06-30 | 28.03M shares 10-Q · filed 2020-07-30 |
| 2020-03-31 | 27.95M shares 10-Q · filed 2020-04-30 |
| 2019-12-31 | 27.95M shares 10-K · filed 2021-03-25 |
| 2019-09-30 | 29.41M shares 10-Q · filed 2019-10-29 |
| 2019-06-30 | 29.35M shares 10-Q · filed 2019-08-01 |
| 2019-03-31 | 29.33M shares 10-Q · filed 2019-05-09 |
| 2018-12-31 | 29.32M shares 10-K · filed 2020-03-09 |
| 2018-09-30 | 29.28M shares 10-Q · filed 2018-11-01 |
| 2018-06-30 | 29.20M shares 10-Q · filed 2018-08-02 |
| 2018-03-31 | 29.18M shares 10-Q · filed 2018-05-03 |
| 2017-12-31 | 21.04M shares 10-K · filed 2019-03-07 |
| 2017-09-30 | 20.94M shares 10-Q · filed 2017-11-02 |
| 2017-06-30 | 20.93M shares 10-Q · filed 2017-08-03 |
| 2017-03-31 | 20.93M shares 10-Q · filed 2017-05-04 |
| 2016-12-31 | 20.92M shares 10-K · filed 2018-03-01 |
| 2016-09-30 | 20.91M shares 10-Q · filed 2016-11-03 |
| 2016-06-30 | 20.91M shares 10-Q · filed 2016-08-04 |
| 2016-03-31 | 20.41M shares 10-Q · filed 2016-05-05 |
| 2015-12-31 | 1.43M shares 10-K · filed 2017-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Apnimed, Inc. (APMD) | United States | $0.899B |